E8TN.F 25.6 (+0.39%)
FR0013240934Medical Diagnostics & ResearchDiagnostics & Research

Eurobio Scientific (E8TN.F) Competitor Comparison

We are evaluating the key criteria listed to compare Eurobio Scientific (E8TN.F) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - E8TN.F ranking 0 / 58

These are the competitors of Eurobio Scientific in the industry Diagnostics & Research ranked by linearity 3 years
1. Danaher DHR
141.18
2. Thermo Fisher Scientific TMO
110.7
3. Quest Diagnostics DGX
87.63
4. Waters WAT
40.39
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Mettler-Toledo MTD
29.11
7. Icon ICLR
24.34
8. IQVIA Holdings IQV
23.19
9. Laboratory Corp of America Holdings LH
17.13
10. Natera NTRA
16.75
11. PerkinElmer PKI
16.14
12. Agilent Technologies A
15.15
13. Syneos Health SYNH
10.68
14. Qiagen QGEN
9.38
15. Heska HSKA
7.67
16. Bioventus BVS
6.78
17. Exact Sciences EXAS
6.77
18. Olink Holding OLK
6.67
19. Anixa Biosciences ANIX
6.51
20. IDEXX Laboratories IDXX
5.97
21. Myriad Genetics MYGN
5.9
22. Sera Prognostics SERA
4.54
23. DexCom DXCM
4.39
24. National Research NRC
4.27
25. Sotera Health SHC
4.23
26. Global Cord Blood CO
4.22
27. Charles River Laboratories CRL
3.14
28. Enzo Biochem ENZ
2.8
29. Psychemedics PMD
2.65
30. Neogen NEOG
2.62
31. Illumina ILMN
2.58
32. MaxCyte MXCT
2.55
33. Fulgent Genetics FLGT
2.25
34. Twist Bioscience TWST
2.09
35. Trinity Biotech TRIB
2.05
36. MDxHealth MDXH
2.04
37. NeoGenomics NEO
2.02
38. Neuronetics STIM
1.98
39. Medpace Holdings MEDP
1.95
40. Guardant Health GH
1.94
41. Co-Diagnostics CODX
1.88
42. Exagen XGN
1.86
43. Interpace Biosciences IDXG
1.85
44. CareDx CDNA
1.81
45. Organovo Holdings ONVO
1.79
46. DarioHealth DRIO
1.79
47. Inotiv NOTV
1.76
48. Precipio PRPO
1.74
49. Pacific Biosciences of California PACB
1.73
50. bioAffinity Technologies BIAF
1.72
51. Prenetics Global PRE
1.71
52. Biodesix BDSX
1.69
53. Personalis PSNL
1.61
54. SeqLL SQL
1.48
55. Aspira Womens Health AWH
1.38
56. RadNet RDNT
0.8
57. Meridian Bioscience VIVO
0.73
58. Lantheus Holdings LNTH
0.53

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.